Skip to content

Delcath Systems

US · DCTH #3706 by market cap
18.79 -0.45 -2.34%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Delcath Systems

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Founded
1988
CEO
Mr. Gerard J. Michel
Employees
156
Headquarters
Queensbury, New York, United States of America
Fiscal year end
12-31
Website
delcath.com

Company profile

Exchange
US
Symbol
DCTH
Market-cap rank
#3706
Market cap
653.67M
Float cap
495.35M
Shares out
34.79M
Float shares
26.36M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Delcath Systems discussion 0 comments

Add a comment